Condensed Consolidated Statements of Operations - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development expenses		$ 13,541	$ 10,283
General and administrative expenses		5,238	2,752
Total operating expenses		18,779	13,035
Loss from operations		(18,779)	(13,035)
Other income (expense):
Interest income		2,320	777
Interest expense		(3)	(2)
Other income		143	0
Other expense		(602)	(3)
Net loss		$ (16,921)	(12,263)
Per share information
Net income (loss) per share, basic (in dollars per share)	[1]	$ (1.00)
Net income (loss) per share, diluted (in dollars per share)	[1]	$ (1.00)
Weighted-average shares outstanding used in computing net income (loss) per share, basic (in shares)	[1]	16,903,735
Weighted-average shares outstanding used in computing net income (loss) per share, diluted (in shares)	[1]	16,903,735
Class A Common Stock
Other income (expense):
Net loss			$ (12,263)
Per share information
Net income (loss) per share, basic (in dollars per share)	[1]		$ (28.28)
Net income (loss) per share, diluted (in dollars per share)	[1]		$ (28.28)
Weighted-average shares outstanding used in computing net income (loss) per share, basic (in shares)	[1]		433,623
Weighted-average shares outstanding used in computing net income (loss) per share, diluted (in shares)	[1]		433,623
Class B Common Stock
Other income (expense):
Net loss			$ 0
Per share information
Net income (loss) per share, basic (in dollars per share)			$ 0
Net income (loss) per share, diluted (in dollars per share)			$ 0
Weighted-average shares outstanding used in computing net income (loss) per share, basic (in shares)			0
Weighted-average shares outstanding used in computing net income (loss) per share, diluted (in shares)			0

[1] For the three months ended March 31, 2023, net loss per share information is presented for the Company’s then outstanding Class A common stock. For the three months ended March 31, 2024, net loss per share information is presented for the Company’s common stock.